|
|
|
|
|
Legal status
Patent lapsed (non-payment of fees)
| (51) | INT.CL. | G01N 33/574 | (2006.01) |
| (11) | Number of the document | 2742356 |
| (13) | Kind of document | T |
| (96) | European patent application number | 12754124.1 |
| Date of filing the European patent application | 2012-08-08 | |
| (97) | Date of publication of the European application | 2014-06-18 |
| (45) | Date of publication and mention of the grant of the patent | 2016-04-27 |
| (46) | Date of publication of the claims translation | 2016-07-11 |
| (86) | Number | PCT/US2012/049941 |
| Date | 2012-08-08 |
| (87) | Number | WO 2013/022935 |
| Date | 2013-02-14 |
| (30) | Number | Date | Country code |
| 201161522596 P | 2011-08-11 | US | |
| 201161560555 P | 2011-11-16 | US |
| (72) |
RICCI, Deborah, US
LI, Weimin, US
HENITZ, Erin, Devay, US
|
| (73) |
Janssen Pharmaceutica N.V.,
Turnhoutseweg 30, 2340 Beerse,
BE
|
| (74) |
Jurga PETNIŪNAITĖ,
AAA Law, A. Goštauto g. 40B, Verslo centras "Dvyniai", LT-03163 Vilnius,
LT
|
| (54) | Prognostinis požymis vėžio gydymui |
| PREDICTORS FOR CANCER TREATMENT |
| Payment date | Validity (years) | Amount | |
| 2020-07-24 | 9 | 208.00 EUR |
| Patent lapsed (non-payment of fees) | ||
| Invalidation date | 2021-08-08 |